Regeneration and bioengineering of transplantable abdominal organs: Current status and future challenges

Expert Opinion on Biological Therapy

Volumn 13, Issue 1, 2013, Pages 103-113

  Ross, Christina L ^a   Booth, Christopher ^a   Sanders, Brian ^a   Babbar, Paurush ^a   Bergman, Christopher ^a   Soker, Tom ^a   Sittadjody, Sivanandane ^a   Salvatori, Marcus ^b   Al Shraideh, Yousef ^a   Stratta, Robert J ^a   Orlando, Giuseppe ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Immunocloacking; Immunoisolation; Islet encapsulation; Regenerative medicine

Indexed keywords

ALBUMIN; BILIRUBIN; CISPLATIN; GLYCEROL; GRANULOCYTE COLONY STIMULATING FACTOR; LAMININ; TISSUE SCAFFOLD;

BILIRUBIN METABOLISM; BIOENGINEERING; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL JUNCTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; DECELLULARIZATION RECELLULARIZATION TECHNOLOGY; DECOMPENSATED LIVER CIRRHOSIS; ENDOCRINE PANCREAS FUNCTION TEST; ENDOTHELIUM INJURY; EX VIVO STUDY; EXTRACELLULAR MATRIX; GLUCOSE METABOLISM; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; KIDNEY; LIVER; MESENCHYMAL STEM CELL; NONHUMAN; ORGAN TRANSPLANTATION; ORGANOGENESIS; PANCREAS ISLET BETA CELL; PHASE 1 CLINICAL TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; SMALL INTESTINE; SMOOTH MUSCLE RELAXATION; TECHNOLOGY; TISSUE REGENERATION;

ABDOMEN; BIOENGINEERING; HUMANS; ORGAN TRANSPLANTATION; REGENERATION;

EID: 84870902898     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.732063     Document Type: Review

References (90)

1. Zhang Y, McNeill E, Tian H, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol 2008;180:2226-33
2. Orlando G, Wood KJ, De Coppi P, et al. Regenerative medicine as applied to general surgery. Ann Surg 2012;255(5):867-80
3. Yen T, Alison M, Cook H, et al. The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment. Cell Prolif 2007;40:143-56
4. Yuen D, Gilbert RE, Marsden PA. Bone marrow cell therapies for endothelial repair and their relevance to kidney disease. Semin Nephrol 2012;32:215-23
5. Herrera M, Bussolati B, Bruno S, et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004;14:1035-41
6. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008;26:2075-82
7. Rosines E, Johkura K, Zhang X, et al. Constructing kidney-like tissues from cells based on programs for organ development: Towards a method of in vitro engineering of the kidney. Tissue Eng Part A 2010;16:2441-55
8. Steer D, Nigam S. Developmental approaches to kidney tissue engineering. Am J Physiol Renal Physiol 2004;286:F1
9. Rogers S, Talcott M, Hammerman M, et al. Transplantation of pig metanephroi. ASAIO J 2003;49(1):48-52
10. Dekel B, Amariglio N, Kaminski N, et al. Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is. accompanied by a profile of gene expression similar to normal human kidney development. J Am Soc Nephrol 2002;13:977-90
11. Dekel B, Burakova T, Arditti F, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med 2003;9:53-60
12. Orlando G, Baptista P, Mirchall M. Regenerative medicine as applied to solid organ transplantation: Current status and future challenges. Transplant Int 2011;24:223-32
13. Orlando G, Wood KJ, Stratta RJ, et al. Regenerative medicine and organ transplantation: Past, present and future. Transplantation 2011;91:1310-17
14. Ross E, Williams M, Hamazaki T, et al. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 2009;20:2338-47
15. Liu C, Liu SR, Xu AB, et al. Preparation of whole-kidney acellular matrix in rats by perfusion. Nan Fang Yi Ke Da Xue Xue Bao 2009;29(5):979-82
16. Nakayama K, Batchelder C, Lee C, et al. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A 2010;16:2207-16
17. Orlando G, Farney AC, Iskandar SS, et al. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal b ioengineering investigation. Ann Surg 2012;256:363-70
18. Sullivan D, Mirmalek-Sani SH, Deegan DB, et al. Decellularization methods of procine kidneys for whole organ engineering usig a high-throughput system. Biomaterials 2012; [Epub ahead of print]
19. Ricordi C, Lacy P, Finke E, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-20
20. Bellin M, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008;8:2463-70
21. Scharp D, Lacy P, Santiago J, et al. Results of our first nine intraportal islet allografts in type 1, sinulin-dependent diabetic patietns. Transplantation 1991;51(1):6-85
22. Bretzel R, Brandhorst D, Brandhorst H, et al. Improved survival of intraportal pancreatic islet cell allografts in patietns with type-1 diabetes mellitus by refined peritransplant management. J Mol Med 1999;77(1):140-3
23. Socci C, Falqui L, Davalli A. Fresh human islet transplantation to replace pancreatic endocrine functionin type 1 diabetic patients: Report of six cases. Acta Diabetol 1991;28(2):151-7
24. Warnock G, Kneteman N, Ryan E, et al. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35(1):89-95
25. Alejandro R, Lehmann R, Ricordi C, et al. Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 1997;46(12):1983-9
26. Sambanis A. Encapsulated islets in diabetes treatment. Diabetes Tehcnol Ther 2003;5(4):665-8
27. Beck J, Angus R, Madsen B, et al. Islet encapsulation: Ptrategies to enhanve islet cell functions. Tissue Eng Part A 2007;13(3):589-99
28. de la Tour D, Halvorsen T, Demeterco C, et al. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001;15:476
29. Nishijima H, Yasunari T, Nakayama T, et al. Improved applications of the tetracycline-regulated gene depletion system. Biosci Trends 2009;3(5)61-7
30. Ravassard P, Hazhouz Y, Pechberty S, et al. A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 2011;121(9):3589-97
31. Efrat S, Fusco-DeMane D, Lemberg H, et al. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 1995;11(92):8
32. Fleischer N, Chen C, Surana M, et al. Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 1998;47(9):1419-25
33. Milo-Landesman D, Surana M, Berkovich I, et al. Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory system. Cell Transplant 2001;10(7):645-50
34. Touchefeu Y, Harrington KJ, Galmiche JP, Vassaux G. Review article: Gene therapy, recent developments and future prospects in gastrointestinal oncology. Ailment Pharmacol Ther 2010;32(8):953-68
35. Furth M, Atala A. Stem cell sources to treat diabetes. J Cell Biochem 2009;106:507-11
36. Kadam S, Bhonde R. Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesechymal stem cells. Islets 2010;2:112-20
37. Le Douarin N, Creuzet S, Couly G, et al. Neural crest cell plasticity and its limits. Development 2004;131:4637-50
38. Huang C, Pelaez D, Dominguez-Bendala J, et al. Plasticity of stem cells derived from adult peridontal ligament. Regen Med 2009;4:809-21
39. Kang H, Kim J, Park S. Insulin-secreting cells from human eyelid-derived stem cells allegiate type 1 diabetes in immunocompetent mice. Stem Cells 2009;4:1999-2008
40. Paredes B, Santana A, Arribas M. Phenotypic differences during the osteogenic differentiation of single-cell derived clones isolated from human lipoaspirates. J Tissue Eng Regen Med 2011;5:589-99
41. Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-32
42. Opara E, Mirmalek-Sani S, Khanna O, et al. Design of a bioartificial pancreas (+). J Investig Med 2010;58(7):831-7
43. Chatenoud L, You S, Okada H, et al.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Immune therapies of type 1 diabetes: New opportunities based on the hygiene hypothesis. Clin Exp Immunol 2010;160(1):106-12
44. Huang G, Greenspan DS. ECM roles in the function of metabolic tissues. Trends Endocrinol Metab 2012;23:16-22
45. Weber L, Hayda KN, Anseth KS. Cell-matrix interactions improve beta-cell survival and insulin secretion in three-dimensional culture. Tissue Eng Part A 2008;14:1959-68
46. Weber L, Anseth KS. Hydrogel encapsulation environments functionalized with extracellular matrix interactions increase islet insulin secretion. Matrix Biol 2008;27:667-73
47. De Carlo E, Baiguera S, Conconi M, et al. Pancreatic acelllular matrix supports islet survival and function in a synthetic tubular device: In vitro and in vivo studies. Int J Mol Med 2010;25:195-202
48. Minuk G. Hepatic regeneration: If it ain't broke, don't fix it. Can J Gastroenterol 2003;17:418-24
49. Kay M, Fausto N. Liver regeneration: Prospects for therapy based on new technologies. Mol Med Today 1997;3:108-15
50. Igarashi Y, D'hoore W, Goebbels RM, et al. Beta-5 score to evaluate pig islet graft function in a primate pre-clinical model. Xenotransplantation 2010;17(6):449-59
51. Petersen B, Bowen W, Patrene K, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-70
52. Theise N, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology 2000;32:11-16
53. Alison M, Poulsom R, Jeffery R, et al. Hepatocytes from nonhepatic adult stem cells. Nature 2000;406:257
54. Oh S, Witek RP, Bae SH, et al. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 2007;132(3):1077-87
55. Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292-8
56. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10:459-66
57. Mohamadnejad M, Namiri M, Bagheri M, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007;13:3359-63
58. Piscaglia A, Shupe T, Oh S, et al. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007;133:619-31
59. Gaia S, Smedile A, Omede P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006;45:13-19
60. Di Campli C, Zocco M, Saulnier N, et al. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis 2007;39:1071-6
61. Spahr L, Lambert J, Rubbia-Brandt L, et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: A randomized trial. Hepatology 2008;48:221-9
62. Uygun B, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010;16:814-20
63. Baptista P, Siddiqui M, Lozier G, et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011;53:604-17
64. Shupe T, Williams M, Brown A, et al. Method for the decellularization of intact rat liver. Organogenesis 2010;6:134-6
65. Wang Y, Cui C, Yamauchi M, et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissuespecific biomatrix scaffolds. Hepatology 2011;53:293-305
66. Soto-Gutierrez A, Zhang L, Medberry C, et al. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 2011;17:677-86
67. Sellaro T, Ranade A, Faulk D, et al. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A 2010;16:1075-82
68. Lin P, Chan W, Badylak S, et al. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng Part A 2004;10:1046-53
69. Sellaro T, Ravindra A, Stolz D, et al. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng Part A 2007;13:2301-10
70. De Kock J, Ceelen L, De Spiegelaere W, et al Simple and Quick Method for Whole-liver Decellularization: A Novel in Vitro Three-dimensional Bioengineering Tool? Arch Toxicol 2011;85:607-1
71. Orlando G, Garcia-Arraras J, Soker T, et al. Regeneration and bioengineering of the gastrointestinal tract: Current status and future perspectives. Dig Liver Dis 2012; In press
72. Orlando G, Garcia-Arraras J, Soker T, et al. Regeneration and bioengineering of the gastrointestinal tract: Current status and future perspectives. Dig Liver Dis 2012;44(9):714-20
73. Chen M, Badylak S. Small bowel tissue engineering using small intestinal submucosa as a scaffold. J Surg Res 2001;99:352-8
74. Baptista P, Orlando G, Mirmalek-Sani S, et al. Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc 2009;6526-9
75. McCracken K, Howell J, Wells J, et al. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc 2011;6:1920-8
76. Grikscheit T, Siddique A, Ochoa E, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004;240:748-54
77. Grikscheit T, Ochoa ER, Ramsanahie A, et al. Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg 2003;238:35-41
78. Medema J, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011;474:318-26
79. Smith N, Anderson E, Davies P, et al. Building blocks for engineering the intestines: Insights into intestinal stem cells and their propagation. EMBO Mol Med 2009;1(5):255-9
80. Jiang Y, Jahagirdar B, Reinhardt R, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9
81. Hori Y, Nakamura T, Kimura D, et al. Experimental study on tissue engineering of the small intestine by mesenchymal stem cell seeding. J Surg Res 2002;102:156-60
82. Wang Z, Watanabe Y, Toki A. Experimental assessment of small intestinal submucosa as a small bowel graft in a rat model. J Pediatr Surg 2003;38:1596-601
83. Lee M, Wu B, Stelzner M, et al. Intestinal smooth muscle cell maintenance by basic fibroblast growth factor. Tissue Eng Part A 2008;14:1395-402
84. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med 1973;138:745-53
85. Geneva, W. W.H.O.-. Global health risks: Mortality and burden of disease attributable to selected major risks. World Health Organization, 2009. Available from: Http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks- report-full.pdf [December 2009]
86. Narayan K, Ali MK, Koplan JP. Global noncommunicable diseases-where worlds meet. N Engl J Med 2010;363:1196-8
87. Hollander A, Macchiarini P, Gordijn B, et al. The first stem cell-based tissue engineered organ replacement: Implications for regernative medicine and society. Regen Med 2009;4:147-8
88. Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation 2011;92(8):e36-8
89. Orlando G. Transplantation as a subfield of regenerative medicine: An interview by Lauren Constable. Expert Rev Clin Immunol 2011;7:137-41
90. Orlando G, Soker S, Wood K. Clinical operational tolerance after liver transplantation. J Hepatol 2009;50:1247-57